Pharmacotherapeutic group: G03GA05 - gonadotropin. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU FSH and 75 IU LH vial., Lyophillisate for Mr injection of 150 IU in vial. Contraindications to the use of drugs: pregnancy, increase or ovarian cysts not related to c-IOM polycystic ovarian gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast cancer, tumors of the hypothalamus or pituitary gland; hypersensitivity to the drug; cases of effective responses response to treatment can develop, for here through: the primary pathology of ovarian defects of genital organs incompatible with pregnancy; fibroyidni tumors of the uterus incompatible with pregnancy enrolment . Indications for use enrolment anovulatory cycle (including c-m polycystic ovaries) in women who are not sensitive to treatment Clomifenum citrate; of assisted reproductive technologies (ART). Method of production of drugs: lyophilized powder for making Mr injection of 75 IU in vial., Lyophillisate for Mr enrolment of 75 IU, 150 IU in vial. Side effects and complications in the use of drugs: local reactions, increasing t °, joint pain, can not exclude the possibility of ovarian hyperstimulation, arterial thromboembolism, pregnancy loss rate due to her miscarriage or spontaneous abortion is not much Left Lower Lobe from frequency observed among women with other reproductive disorders, women with tubal pathology may develop a history of ectopic pregnancy.
ไม่มีความคิดเห็น:
แสดงความคิดเห็น